GenSight Biologics

A clinical-stage biotechnology company developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system.

[GenSight Biologics @GenSightBio]

GenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - https://t.co/EgVktPFD0A
#genetherapy #biologics #rarediseases #executivepositions #LHON #Ophthalmology

[GenSight Biologics @GenSightBio]

GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of LUMEVOQ® Vector DNA in Contralateral Eyes After Unilateral Injection | Business Wire
https://t.co/JKkM5lkDlF

[GenSight Biologics @GenSightBio]

GenSight Biologics invite Julien Secheyron, « Patient N°15 » de la 1ère étude clinique de LUMEVOQ®, à venir présenter son livre « Vous ne verrez plus »

https://t.co/RGGfiuOsww

[GenSight Biologics @GenSightBio]

GenSight Biologics reports second patient case showing significant visual recovery after GS030 optogenetic treatment in the PIONEER Phase I/II trial
Patient video on https://t.co/wYGhbzvbrn

#Optogenetics #Ophthalmology #retinitis #blindness #AAO2021

[GenSight Biologics @GenSightBio]

GenSight Biologics Announces Extension of Day 120 Clock Stop of LUMEVOQ® EMA Regulatory Filing; MAA Review to Resume in April 2022 | Business Wire

https://t.co/uNZzGSibgL

[GenSight Biologics @GenSightBio]

GenSight Biologics Reports Cash Position as of September 30, 2021 and Provides Operational Update | Business Wire

https://t.co/aJTfqk2si8

[Ophthalmology Times @OphthTimes]

Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: https://t.co/emkWEzgCDn

@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy

[VJRegenMed @VJRegenMed]

Magali Taiel of @GenSightBio discusses LUMEVOQ #genetherapy for Leber hereditary optic neuropathy

Watch: 👉 https://t.co/SlXFh1J296 👈

@alliancerm #CGMesa21 #ophthamology #RegenerativeMedicine

[GenSight Biologics @GenSightBio]

Dr Magali Taiel will present at @alliancerm Cell & Gene Meeting on the Mesa about LUMEVOQ® #genetherapy to treat #lhon #rarediseases #blindness under regulatory review #EMA for European #maa expected in H1 2022
#CGMesa21 #RegenerativeMedicine #retina #ophthalmology

[DelveInsight @delve_insight]

@LandosBio’s LABP-104 gets Approved for #SLE #treatment.
#NIH Grant of USD 3 million to @AmydisInc for exploring #ASYN.
#USFDA Grant to @GenSightBio’ #GS030 for #RetinitisPigmentosa.

For more details, visit https://t.co/f91pXepu5X. (2/2)

#pharma #biotech #news #pharmanews

[BioPharmAnalyses @anneliseberthie]

Fast track designation for @GenSightBio's gene therapy GS030 https://t.co/ZhH2lS9ohw

[GenSight Biologics @GenSightBio]

@US_FDA has granted Fast Track Designation to GS030, which combines AAV2-based #genetherapy with #optogenetics to treat #retinitispigmentosa
It highlights the significant unmet need for a safe and effective treatment of all forms of RP @bernard_gilly
https://t.co/MFnoSiF9wI

[Nouvel Obs Eco @NouvelObs_Eco]

La start-up française @GenSightBio a mis au point une thérapie génique qui redonne leur autonomie aux patients atteints de la maladie de Leber, qui rend quasi-aveugle en quelques semaines https://t.co/aRTNu9v7lL récit par @domnora

[Ophthalmology Times @OphthTimes]

Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: https://t.co/1K9Dzf7eUQ

@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy

[Science & Alliance - UMDF @UMDFScience]

@GenSightBio announces that the peer reviewed journal International Ophthalmology Clinics has published a review of all current and past gene therapy trials for LHON. To read more, go to https://t.co/jAfkvEW3p7 #Clinicaltrials #LHON

[GenSight Biologics @GenSightBio]

Just published in the peer-reviewed International Ophthalmology Clinics
- Bilateral treatment effect following unilateral injection of #genetherapy independently reported by three research groups
- LUMEVOQ® for #LHON first #genetherapy requesting #maa #EMA
https://t.co/94TN74k4f6

[stepbystef @AILLEURS2507]

$sight

[GenSight Biologics @GenSightBio]

Join us at Chardan 5th Annual Genetic Medicines Conference #ChardanGMConf #CGMC2021
@bernard_gilly to present on Monday Oct. 4, 2021 8.00am ET. Webcast of the fireside chat to be available at https://t.co/MSG5S0c5MY for 90 days
#genetherapy #cellandgenetherapy #rarediseases #LHON

[Ophthalmology Times @OphthTimes]

Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: https://t.co/wNoehqpA6H

@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy

[Ophthalmology Times @OphthTimes]

Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: https://t.co/MwKrgTGrze

@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy